LIR_6 Inhibitors
LIR_6 inhibitors encompass a diverse array of chemical compounds that exert their inhibitory effects through various biochemical mechanisms. Certain compounds, by altering lysosomal pH, can impede the degradation processes essential for the proper functioning of LIR_6 within immune regulation. Tyrosine kinase inhibitors exert their effects by targeting pathways such as EGFR, which, when inhibited, can reduce the immunoregulatory functions potentially modulated by LIR_6. The use of agents that prevent T-cell activation can lead to a decrease in the functional activity of LIR_6 as it is reliant on the activation state of immune cells. Similarly, compounds that modulate inflammatory responses, either through inhibition of the NF-kB pathway or COX enzymes, can result in the downregulation of LIR_6 activity, assuming it is influenced by these inflammatory pathways.
Furthermore, the inhibition of intracellular pathways by targeting kinases involved in cell growth, proliferation, and immune cell regulation is another strategy to alter LIR_6 activity. Agents that inhibit the mTOR signaling or BCR-ABL tyrosine kinase can disrupt immune cell function, thereby potentially diminishing the activity of LIR_6. Inhibitors that interferewith chemokine receptors or multiple receptor tyrosine kinases impact the immune response, which could have an indirect inhibitory effect on LIR_6, assuming it is involved in these processes. Additional mechanisms include the use of compounds that inhibit key enzymes in nucleotide synthesis or angiogenesis, leading to reduced proliferation and activation of immune cells, which is critical for LIR_6 function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent protein kinase inhibitor that can affect multiple signaling pathways including those that regulate immune cell function. By inhibiting protein kinases, it can impair signal transduction processes that are essential for LIR_6 activation and function. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Binds to the cytosolic protein cyclophilin of immunocompetent lymphocytes, especially T-lymphocytes. This complex of cyclosporine and cyclophilin inhibits calcineurin, which is normally responsible for activating T-cells by dephosphorylating the nuclear factor of activated T-cells (NF-AT), a transcription factor. As LIR_6 is expressed on leukocytes, its functional activity is likely to be diminished due to the reduced T-cell activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A specific inhibitor of phosphoinositide 3-kinases (PI3Ks) which are involved in the signaling pathways that affect the survival and activation of various immune cells. Inhibition of PI3K signaling can lead to reduced cellular responses and hence the functional activity of LIR_6. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A selective inhibitor of mitogen-activated protein kinase kinase (MEK), which is involved in the MAPK/ERK pathway. This pathway plays a role in lymphocyte proliferation and differentiation. Inhibiting this pathway can reduce the activation state of immune cells expressing LIR_6. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
A macrolide compound that inhibits mTOR (mammalian target of rapamycin) and thereby can dampen T-cell proliferation and activation. As LIR_6 is part of leukocyte function, mTOR inhibition would likely decrease the functional activity of LIR_6-expressing cells. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor, which affects the AKT signaling pathway, crucial for the regulation of cell survival and apoptosis. This inhibition can downregulate immune cell activity and thus the role of LIR_6 in these cells. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
An inhibitor of NF-κB activation by blocking phosphorylation of IκBα, thus preventing the translocation of NF-κB to the nucleus. Since NF-κB is integral to immune cell function, inhibiting it would suppress LIR_6-mediated signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A pyridinyl imidazole compound that selectively inhibits p38 MAP kinase, which is involved in cytokine production and T-cell differentiation. This can lead to a reduction in LIR_6-mediated signaling in leukocytes. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
An inhibitor of both MEK1 and MEK2, which blocks the MAPK/ERK pathway, leading to decreased lymphocyte activation and potentially diminishing the activity of LIR_6 in these cells. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A selective inhibitor of c-Jun N-terminal kinase (JNK), which is part of the MAPK pathway. By inhibiting JNK, this compound can alter T-cell function and thus decrease the signaling activity of LIR_6. | ||||||